Drug Profile
R 701
Alternative Names: R701Latest Information Update: 19 May 2004
Price :
$50
*
At a glance
- Originator Roche
- Class
- Mechanism of Action G protein-coupled receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Overactive bladder
Most Recent Events
- 30 Apr 2004 Discontinued - Phase-I for Overactive bladder in Europe (unspecified route)
- 17 Apr 2002 Phase-I clinical trials in Overactive bladder in Europe (unspecified route)